Finland Pharmaceuticals Tenders

Finland's pharmaceuticals market is a steady performer, expected to reach a cool US$2.58 billion by 2028, growing at a steady clip of 5% per year. This makes it an attractive market for both domestic and international players.

The Finnish government is a big spender on pharmaceuticals, shelling out an estimated €2.9 billion in 2021. This covers a wide range of products and services, from essential drugs to cutting-edge medical technology.

The government's shopping list includes:
Prescription drugs: These are the big-ticket items, used to treat chronic and acute conditions. Think insulin, cancer meds, and the like.
Over-the-counter (OTC) meds: Painkillers, cough syrups, and other self-treatable goodies fall under this category.
Hospital supplies: Bandages, syringes, and other essentials for keeping healthcare facilities running smoothly.
Vaccinations: Keeping the Finnish population immunized is a top priority.

Several key authorities oversee government pharmaceutical procurement:
Fimea: The Finnish Medicines Agency ensures all drugs are safe and effective before they hit the shelves.
Kela: The Social Insurance Institution of Finland handles reimbursement for prescription drugs.
Hospital districts: These local bodies handle procurement for their own hospitals and clinics.

Some of the top winners in Finland's pharmaceutical procurement game include:
Pfizer: This global pharma giant snagged a hefty €240 million contract for pneumococcal vaccines in 2020.
Orion: Finland's own pharma champion is a leader in generic drugs and has a strong presence in the local market.
Bayer: This German company is another major player, supplying essential drugs like aspirin and blood thinners.

Tags -
Finland pharmaceutical tenders, Finland pharmaceuticals bids contracts, Finland pharmaceutical government tenders, Finland pharmaceutical global tenders, Finland free pharmaceutical tenders, Finland drugs tenders, Finland medicine tenders, Finland generic medicine tenders